Subjective health values of individuals with diabetes in Japan: Comparison of utility values with the SF-36 scores

Diabetes Research and Clinical Practice

Volumn 62, Issue 1, 2003, Pages 9-16

  Ohsawa, Isao ^a   Ishida, Taemi ^b   Oshida, Yoshiharu ^a   Yamanouchi, Kunio ^c   Sato, Yuzo ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b TOKAI GAKUEN UNIVERSITY   (Japan)

^c AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetes; Preference; Quality of life; SF 36; Utility

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; FEMALE; HEALTH BEHAVIOR; HOSPITALIZATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; VISUAL ANALOG SCALE;

EID: 0142199863     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(03)00145-1     Document Type: Article

References (27)

1. Sox H.C., Blatt M.A., Higgins M.C., Marton K.I. Decision making when the outcomes have several dimensions. Medical Decision Making. 1988;201-237 Butterworths-Heinemann, Boston, MA.
2. Weinstein M.C., Fineberg H.V. Utility analysis: Clinical decisions involving many possible outcomes. Clinical Decision Analysis. 1980;184-227 WB Saunders Company, Philadelphia, PA.
3. Froberg D.G., Kane R.L. Methodology for measuring health-state preferences: II. Scaling methods. J. Clin. Epidemiol. 42:1989;459-471.
4. Drummond M.F., O'Brien B.J., Stoddart G.L., Torrance G.W. Cost-utility analysis. Methods for the Economic Evaluation of Health Care Programmes. second ed. 1997;139-204 Oxford University Press, New York, NY.
5. Torrance G.W., Feeny D., Furlong W. Visual analog scales: do they have a role in the management of preferences for health states? Med. Decis. Making. 21:2001;329-334.
6. Ohsawa I., Ishida T., Mori K., et al. Subjective valuation for the quality of life in individuals with diabetes mellitus by utility assessment. J. Jap. Diab. Soc. 42:1999;341-346.
7. Gill T.M., Feinstein A.R. A critical appraisal of the quality of quality-of-life measurements. J. Am. Med. Assoc. 272:1994;619-626.
8. Guyatt G.H., Feeny D.H., Patrick D.L. Measuring health-related quality of life. Ann. Intern. Med. 118:1993;622-629.
9. Ware J.E., Snow K.K., Kosinski M., Gandek B. SF-36 Health Survey Manual and Interpretation Guide. 1993;New England Medical Center, The Health Institute, Boston, MA.
10. Riegelman R.K. Assessment. Studying a Study and Testing a Test. How to Read the Health Science Literature. fourth ed. 2000;235-239 Lippincott Williams & Wilkins, Philadelphia, PA.
11. von Neumann J., Morgenstern O. Theory of Games and Economic Behavior. 1953;Wiley, New York, NY.
12. Fukuhara S., Bito S., Green J., Hsiao A., Kurokawa K. Translation, adaptation, and validation of the SF-36 Health Survey use in Japan. J. Clin. Epidemiol. 51:1998;1037-1044.
13. Fukuhara S., Ware J.E. Jr., Kosinski M., Wada S., Gandek B. Psychometric and clinical tests of validity of the Japanese SF-36 health survey. J. Clin. Epidemiol. 51:1998;1045-1053.
14. Fukuhara S., Suzukamo Y., Kurokawa K. Manual of SF-36 Japanese version 1.2. 2001;Public Health Research Center, Tokyo.
15. Read J.L., Quinn R., Berwick D., Finberg H., Weinstein M. Preferences for health outcomes: comparison of assessment methods. Med. Decis. Making. 4:1984;315-329.
16. Ahroni J.H., Davignon D.R., Boyko E.J., Pecoraro R.E. The health and functional status of veterans with diabetes. Diabetes Care. 17:1994;318-321.
17. Gulliford M.C., Mahabir D. Relationship of health-related quality of life to symptom severity in diabetes mellitus: a study in Trinidad and Tobago. J. Clin. Epidemiol. 52:1999;773-780.
18. Klein B.E.K., Klein R., Moss S.E. Self-rated health and diabetes of long duration. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care. 21:1998;236-240.
19. Nerenz D.R., Repasky D.P., Whitehouse F.W., Kahkonen D.M. Ongoing assessment of health status in patients with diabetes mellitus. Med. Care. 30:(Suppl. 5):1992;MS112-MS124.
20. Weinberger M., Kirkman M.S., Samsa G.P., et al. The relationship between glycemic control and health-related quality of life in patients with non-insulin-dependent diabetes mellitus. Med. Care. 32:1994;1173-1181.
21. Anderson R.M., Davis W.K., Fitzgerald J.T., Hiss R.G., Wisdom K. A comparison of global versus disease-specific quality-of-life measures in patients with NIDDM. Diabetes Care. 20:1997;299-305.
22. Jacobson A.M., Samson J.A., De Groot M. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care. 17:1994;267-274.
23. Brown G.C., Brown M.M., Sharma S., Brown H., Gozum M., Denton P. Quality of life associated with diabetes mellitus in an adult population. J. Diabetes Complicat. 14:2000;18-24.
24. Brown M.M., Brown G.C., Sharma S., Shah G. Utility values and diabetic retinopathy. Am. J. Ophthalmol. 128:1999;324-330.
25. Douzdjian V., Ferrara D., Silvestri G. Treatment strategies for insulin-dependent diabetes with ESRD: a cost-effectiveness decision analysis model. Am. J. Kidney Dis. 31:1998;794-802.
26. UK Prospective Diabetes Study Group, Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37), Diabetes Care 22 (1999) 1125-1136.
27. Clark P., Gray A., Holman R. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med. Decis. Making. 22:2002;340-349.